FIRST IN PULSE: PATIENT GROUPS FOCUS COMPLAINTS ON PHASE 2 OF PART B DEMO — More than 40 groups, led by the Partnership to Improve Patient Care, are sending a letter to CMS acting administrator Andy Slavitt today with fresh concerns over the agency's planned Part B demonstration project.
While most criticism of the Part B demo has centered on Medicare's proposed changes to lower its add-on payment for drugs, the patient groups say that phase 2 of the proposal — which would introduce new payment pilots that draw on comparative-effectiveness research — would hurt patients, too.
For instance, the groups take issue with CMS's plan to draw on recommendations from ICER — which the groups contend is led by a governing board that "consists mainly of payers, with no representation from patients or people with disabilities."
"While no doubt a well-intentioned effort to advance value-driven health care, the approach it takes would represent a major step back for patients and people with disabilities," the organizations write.
This morning's edition of Politico Pulse highlighted the Partnership to Improve Patient Care's (PIPC) leadership among patient groups in voicing concerns over Phase 2 of the Centers for Medicare and Medicaid Services (CMS) planned Part B demonstration project. PIPC, along with over 40 other groups, are sending a letter to CMS acting administrator Andy Slavitt highlighting issues with the proposed change to lower the add-on payment for drugs in phase 2 of the proposed demo.
The full entry is available below.